Table 5.

Treatment of Manifestations in Individuals with Usher Syndrome Type I

Hearing loss
  • An initial trial of hearing aids even w/profound loss stimulates any residual hearing & accustoms the infant to auditory stimulation for auditory/oral language development.
  • Cochlear implantation should be considered as early as is medically feasible. 1
Hearing aids are usually inadequate in severe-to-profound hearing loss. Sign language such as American Sign Language and tactile signs (once visual loss occurs) are communication options for families who choose nonauditory communication.
Specialized training from educators of the hearing impairedRecommended for affected children & all family members to improve communication skills
& ↑ risk of
Vestibular compensation therapy for children w/residual balance function & sensory substitution therapy for individuals w/complete absence of vestibular functionWell-supervised sports activities may help develop somatosensory component of the balance system.
Vision loss See Nonsyndromic Retinitis Pigmentosa Overview, Management.Adults w/USH1 age >20 yrs use sign language & lip reading for communication. As vision loss progresses, these methods become increasingly difficult & tactile signing may ultimately be required.

From: Usher Syndrome Type I

Cover of GeneReviews®
GeneReviews® [Internet].
Adam MP, Feldman J, Mirzaa GM, et al., editors.
Seattle (WA): University of Washington, Seattle; 1993-2024.
Copyright © 1993-2024, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.

GeneReviews® chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source ( and copyright (© 1993-2024 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the GeneReviews® Copyright Notice and Usage Disclaimer. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.

For more information, see the GeneReviews® Copyright Notice and Usage Disclaimer.

For questions regarding permissions or whether a specified use is allowed, contact: ude.wu@tssamda.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.